BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, outcomes, and technology company with a focus on chronic conditions, today announced the launch of two new Real-World Analytics products – ...

OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1’s Principal, Real World Evidence.

BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, AI and technology company with a focus on chronic diseases, today announced the appointment of Shawn Bates as Chief Commercial Officer. Bates ...

Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare "Hunter’s track record of building ...

OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior ...

Massive study demonstrates how AI-enabled evidence generation can meet the FDA's bar for decision-making OM1, a real-world evidence generation company and the leading AI outcomes platform, presented ...

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--OM1, a leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced that its Rheumatoid Arthritis ...

OM1 a leading real-world data, outcomes and technology company with a focus on chronic conditions, today announced the enhancement of its Mental Health and Neuroscience Real-World Data to include ...

Harvard trained surgeon and big data entrepreneur Dr. Richard Gliklich has been working to improve the management of chronic conditions by organising, analysing and applying health outcomes data since ...